25
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71840 |
FKBP12-IN-Q2
|
||
FKBP12-IN-Q2 is an inhibitor of FKBP12. | |||
T13694 |
FKBP12 PROTAC RC32
RC32 |
Others | Others |
FKBP12 PROTAC RC32 contains conjugation of Rapamycin and a ligand for an E3 ubiquitin ligase.FKBP12 PROTAC RC32 (RC32) is a potent FKBP12 degrader based on PROTAC technology. | |||
T11291 |
FKBP12 PROTAC dTAG-13
dTAG-13 |
Epigenetic Reader Domain | Chromatin/Epigenetic |
FKBP12 PROTAC dTAG-13 (dTAG-13) is a degrader of FKBP12F36V with expression of FKBP12F36V in-frame with a protein of interest. FKBP12 PROTAC dTAG-13 (dTAG-13) also is a selective degrader of BET bromodomain transcriptional co-activator BRD4 by bridging BET bromodomains to an E3 ubiquitin ligase CRBN. FKBP12 PROTAC dTAG-13 (dTAG-13) is a PROTAC-based heterobifunctional degrader. | |||
T11292 |
FKBP12 PROTAC dTAG-7
dTAG-7 |
Epigenetic Reader Domain | Chromatin/Epigenetic |
FKBP12 PROTAC dTAG-7 (dTAG-7) is a heterobifunctional compound that selectively degrades the BET bromodomain transcriptional co-activator BRD4 by connecting BET bromodomains to the E3 ubiquitin ligase CRBN. Additionally, it serves as a degrader of FKBP12F36V when FKBP12F36V is expressed in-frame with a targeted protein. | |||
T18611 |
AP1867-2-(carboxymethoxy)
PROTAC FKBP12-binding moiety 2 |
Others | Others |
AP1867-2-(carboxymethoxy), a moiety based on the synthetic FKBP12F36V-directed ligand AP1867, connects to the CRBN ligand through a linker to generate dTAG molecules[1]. | |||
T13914 |
SLF-amido-C2-COOH
PROTAC FKBP12-binding moiety 1 |
Others | Others |
SLF-amido-C2-COOH is a synthetic ligand for FKBP (SLF), and can be used in the synthesis of PROTACs. | |||
T40031 |
Thalidomide-O-C6-NH2 hydrochloride
4-((6-aminohexyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride,萨力多胺-O-C6-氨基盐酸盐 |
E3 Ligase Ligand-Linker Conjugate | PROTAC |
Thalidomide-O-C6-NH2 hydrochloride (4-((6-aminohexyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride) 是一种合成的E3 连接酶配体 -linker 偶联物,用于 PROTAC dTAG-13 的合成。其中 dTAG-13 是一种 FKBP12F36V 和 BET 的降解剂。 | |||
T74025 |
AUTAC1
|
AUTACs | PROTAC |
AUTAC1是一种 MetAP2 靶向自噬介导降解体 (AUTAC),具有潜在的抗癌活性,可降解 MetAP2 和 FKBP12 蛋白,可用于合成 PROTAC。 | |||
T14298 |
Rimiducid
|
Apoptosis; Others; Fatty Acid Synthase | Apoptosis; Metabolism; Others |
Rimiducid 是一种可渗透脂质的他克莫司类似物,是一种二聚剂,通过交联 FKBP 结构域起作用。它将 Caspase 9 自杀开关二聚化并迅速诱导细胞凋亡。 | |||
T9950 |
ElteN378
|
mTOR | PI3K/Akt/mTOR signaling |
Elte N378 是一种高效的合成 FKBP12 抑制剂,Ki 为 0.5 nM,是一种低原子量配体,其亲和力与大环内酯类雷帕霉素相当。 | |||
T6033 |
Zotarolimus
ABT-578,佐他莫司,咗他莫司,A 179578 |
mTOR | PI3K/Akt/mTOR signaling |
Zotarolimus (ABT-578) 是一种免疫抑制剂,是雷帕霉素的衍生物,具有抗增殖活性。它被专门开发作为局部输送支架用于预防冠状动脉再狭窄。 | |||
T18597 |
dFKBP-1
|
Others | Others |
dFKBP-1 is a potent and PROTAC-based FKBP12 degrader. dFKBP-1 incorporates the ligand SLF of FKBP12, the Thalidomide based cereblon ligand and a linker[1]. | |||
T40251 |
dTAGV-1 TFA
|
||
dTAGV-1 TFA is a highly effective and specific compound that targets mutant FKBP12 F36V fusion proteins for degradation. It possesses potent activity in inducing the degradation of the FKBP12 F36V -Nluc protein in living organisms. | |||
T73817 | SLF TFA | ||
SLF TFA 是 FK506 结合蛋白 (FKBP) 的合成配体,对FKBP51的亲和力为 3.1 μM,对FKBP12的IC50为 2.6 μM,可用于合成PROTAC 分子。 | |||
T1784 |
Everolimus
依维莫司,RAD001,SDZ-RAD |
Apoptosis; Others; mTOR; Autophagy | Apoptosis; Autophagy; Others; PI3K/Akt/mTOR signaling |
Everolimus (SDZ-RAD) 是 Rapamycin 的衍生物,也是一种口服活性的mTOR1选择性抑制剂。它与FKBP-12结合可产生免疫抑制复合物,还抑制肿瘤细胞增殖并诱导细胞凋亡和自噬,有免疫抑制和抗癌活性。 | |||
T74026 |
AUTAC2
|
||
AUTAC2 是一种 FKBP12靶向自噬介导降解体 (AUTAC)。AUTAC2 包含一个 FBnG 和 SLF 部分,其中 SLF 与 FKBP12 非共价结合。 | |||
T74556 |
dTAG-47
|
||
dTAG-47,异双功能 dTAG 分子,靶向突变型 FKBP12 (FKBP12F36V)。FKBP12F36V 可用作降解标签 (dTAG) 并与靶蛋白融合。dTAG-47可用于基底样乳腺癌(BBC)的研究。 | |||
T18061 | KB02-SLF | Others | Others |
KB02-SLF is a PROTAC-based nuclear FKBP12 degrader, known as a molecular glue. It facilitates the degradation of nuclear FKBP12 by covalently modifying DCAF16, an E3 ligase. Moreover, KB02-SLF enhances the longevity of protein degradation in biological systems. The compound SLF acts as a linker, binding to the ubiquitin E3 ligase ligand KB02, resulting in the formation of KB02-SLF[1]. | |||
T13888 |
SLF
|
Others | Others |
SLF is a synthetic ligand for FK506-binding protein (FKBP)( with an affinity of 3.1 μM for FKBP51 and an IC50 of 0.22 μM for FKBP12). SLF can be used in the synthesis of PROTAC. | |||
T13549 | AP1867-3-(aminoethoxy) | Others | Others |
AP1867-3-(aminoethoxy) is a synthetic ligand for FKBP and can be used in the synthesis of PROTAC FKBP12 F36V degrader. | |||
T80928 |
TSPO ligand-3
|
AUTACs | PROTAC |
TSPO ligand-3为AUTAC2的配体,其中AUTAC2包含p-氟苄基鸟嘌呤(FBnG)及FKBP合成配体(SLF)两部分,能在HeLa细胞中显著沉默FKBP12蛋白。 | |||
T81743 | mTORC1-IN-1 | mTOR | PI3K/Akt/mTOR signaling |
mTORC1-IN-1(compound T1)为一种rapalog及选择性mTORC1抑制剂,调节细胞生长和代谢,与多种疾病如癌症相关。该化合物通过与FKBP12-FRB复合物结合(对接分数−11.6 kcal/mol)来靶向mTORC1。 | |||
T13734 | ILS-920 | Others | Others |
ILS-920 is a Rapamycin analog characterized by diminished immunosuppressive effects but remarkable neuroprotective properties. It exhibits selective binding affinity towards the immunophilin FKBP52 as well as the β1-subunit of L-type voltage-gated calcium channels (VGCC). ILS-920 displays a notable 200-fold preference for FKBP52 over FKBP12. | |||
T74412 | dTAGV-1-NEG TFA | ||
dTAGV-1-NEG TFA 是一种非对映异构体,是 dTAGV-1 的异双功能阴性对照。dTAGV-1-NEG TFA 是一种 FKBP12F36V 选择性降解剂。 | |||
T36253 | dTAGV-1 | ||
Degrader targeting mutant FKBP12F36V fusion proteins. Comprises a ligand selective for F36V single-point mutated FKBP12, a linker and a von Hippel-Lindau (VHL)-binding ligand. Induces potent and selective degradation of FKBP12F36V fusion proteins in vitro and in vivo. Selectively degrades FKBP12F36V-EWS/FLI fusion proteins and inhibits cell proliferation in FKBP12F36V-EWS/FLI-expressing Ewing sarcoma cells. Hydrochloride salt (Cat.No. 7374) available; suitable for in vivo use. Negative control... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2481 |
Ascomycin
FK520,Immunomycin,子囊霉素,FR-900520 |
Phosphatase; Others; Antibiotic; Parasite; Antifungal | Metabolism; Microbiology/Virology; Others |
Ascomycin (Immunomycin) 是 Tacrolimus 的乙基类似物,具有免疫抑制特性。它也是一种大环聚酮类抗生素,具有抗疟疾、抗真菌和抗痉挛等多种生物活性。它可防止移植排斥,并具有用于各种皮肤病研究的潜力。 | |||
T1537 |
Rapamycin
Sirolimus,AY 22989,雷帕霉素,NSC-2260804 |
Others; Endogenous Metabolite; Antibiotic; mTOR; Autophagy; Antifungal | Autophagy; Metabolism; Microbiology/Virology; Others; PI3K/Akt/mTOR signaling |
Rapamycin (AY 22989) 属于大环内酯类天然产物,是一种 mTOR 抑制剂,具有特异性(HEK293 细胞:IC50=0.1 nM)。Rapamycin 具有免疫抑制活性,并能诱导自噬。 | |||
T2144 |
Tacrolimus
他克莫司,Fujimycin,FK506,FR900506 |
Phosphatase; Others; Antibacterial; Antibiotic; mTOR; Autophagy | Autophagy; Metabolism; Microbiology/Virology; Others; PI3K/Akt/mTOR signaling |
Tacrolimus (Fujimycin) 可与 FKBP12 结合形成高亲和力复合物 (Ki: 0.2 nM),抑制钙/钙调蛋白依赖性蛋白磷酸酶的活性。 |